Buy BPC-157 Peptide: A Powder, Not a Prescription Drug
Summary: At the molecule level BPC-157 is a 15-amino-acid synthetic peptide shipped as a dry powder under a research-use label, and that single fact decides everything about what you can buy, where it can legally travel, and what nobody is promising you.
This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.
If you buy BPC-157 peptide, what turns up is a small stoppered vial holding 10 mg of white lyophilised powder, priced at $49.00 list and $24.50 with the code PEPTIDEDECK. It is a chemical, not a medicine, and the whole purchase follows from that.
Where readers actually buy it
Ascension Peptides — BPC-157
Research-grade BPC-157, tested by two outside labs and shipped from the US. The code below takes half off either option.
The Wolverine Stack is BPC-157 10 mg combined with TB-500 10 mg in one vial, so its per-mg figure spans both compounds. Quantity tiers take 3%, 5% or 10% off the list price; free shipping starts at $250.
- Batch certificates from two independent labs
- Free shipping over $250
- Ships same day if ordered before 2pm CST
Sold for laboratory research only and not for human consumption. These are affiliate links: we may earn a commission at no cost to you, and it does not change what we recommend. Prices checked August 19, 2026.
Buy BPC-157 peptide: what the molecule actually is
BPC-157 is a synthetic pentadecapeptide, meaning a chain of 15 amino acids, with the formula C62H98N16O22 and a molecular weight of roughly 1419.5 g/mol. The sequence is based on a fragment of a larger protein identified in gastric juice, which is where the "body protection compound" name comes from. It is made by solid-phase synthesis, purified, then freeze-dried into the powder you receive.
That last step matters more than most listings admit. Peptides of this length are chemically fragile in solution, and a 2026 review in Pharmaceutics catalogues the formulation and stability problems that stand between BPC-157 and any approved dosage form [1]. Selling it dry sidesteps those problems by handing them to whoever reconstitutes it. It also explains why any seller offering BPC-157 pre-mixed in a bottle deserves suspicion: a room-temperature liquid is the format with the shortest honest shelf life.
It is not a GLP-1, and buying it is not a metabolic decision
Readers land here from semaglutide and tirzepatide pages, so this belongs near the top. BPC-157 does not touch the GLP-1 receptor. It is not an incretin, not an appetite drug and not a weight-loss compound, and no trial has ever tested it for that. If you are on a GLP-1, buying BPC-157 changes nothing about that treatment, and it is not something to substitute for it.
Its reputation comes from soft-tissue healing research. A 2025 systematic review in HSS Journal, looking specifically at orthopaedic and sports medicine use, found the evidence base to be preclinical, with the human data limited to small reports rather than controlled trials [2]. The bulk of the underlying work is rat and cell research, much of it produced by one research group in Zagreb. That is a real literature and it is not a clinical one. Our page on what a GLP-1 receptor agonist actually is is the contrast worth holding in mind: approved drugs arrive with a label because somebody had to prove something to get one.
What the listing and the label have to say
A research-chemical listing is not regulated like a drug label, but a serious one still discloses a fixed set of facts. Here is what to look for and what a gap tells you.
| What the listing should state | Why it matters | What a gap means |
|---|---|---|
| Compound name and sequence length | Confirms you are buying BPC-157 and not a fragment or analogue | Vague naming is the oldest substitution trick in this market |
| Net peptide mass, 10 mg | Peptide content and vial fill weight are different numbers | An unstated mass makes per-mg price meaningless |
| Batch or lot number on the vial | Lets you match the vial to a certificate | An unnumbered vial cannot be verified at all |
| Certificate of analysis for that batch | HPLC purity plus mass spec identity from a named lab | A generic PDF with no batch reference proves nothing |
| Named third-party laboratory | Independence from the seller | In-house-only testing is a self-report |
| Physical form, lyophilised powder | Sets storage and handling expectations | Premixed solution is a red flag on stability grounds |
| Research-use-only statement | Defines what is legally being sold | A human-use claim means the seller is misrepresenting the product |
The supplier on this page publishes certificates from two outside labs per batch, Kovera Labs on batch #12-05260628 and MZ Biolabs on batch #12-01260229. Those are the vendor's published documents. We have not run an assay ourselves and we are not in a position to confirm them independently. Our sibling page on judging a BPC-157 supplier turns that list into a scoring exercise.
The purchase itself, in the US
Domestically the transaction is unremarkable. A card checkout, a coupon field where PEPTIDEDECK removes half the subtotal, and a dispatch from US stock. The 10 mg vial is $24.50 after the code, or $2.45 per mg. The Wolverine Stack at $45.00 contains BPC-157 10 mg and TB-500 10 mg together, so its lower headline per-mg figure covers two compounds rather than more BPC-157. Free shipping starts at $250, which one vial does not approach.
There is no prescription step in that sequence, because there is nothing to prescribe. BPC-157 has never been approved by FDA, it holds no USP or NF monograph, and its compounding status shifted twice in 2026 without becoming approval: removed from Category 2 in April 2026 after the nominations were withdrawn, then narrowly recommended for the 503A Bulks List by the Pharmacy Compounding Advisory Committee on 23 and 24 July 2026, a non-binding recommendation with no listing in 21 CFR 216.23 behind it.
BPC-157 where to buy UK, and the part nobody writes down
The UK and EU picture is separate and it has not moved. BPC-157 holds no MHRA authorisation and no EMA marketing authorisation [4], so there is no lawful medicinal supply chain for it in either market. What exists instead is a research-supply grey market, and importing into it carries risks that sit with the buyer.
Three things to be straight about if you plan to buy BPC 157 peptide into the UK or EU from a US storefront:
- The shipment can be stopped. Medicines and medicinal-purpose imports are controlled on entry, and Border Force can detain a parcel [3]. A seized parcel is money gone, and whether a vendor reships is a matter of its policy, not your right.
- Charges land on delivery. Import VAT and a courier handling fee are collected before the parcel is released, and they are calculated on the declared value plus shipping. A $24.50 vial does not stay $24.50 by the time it reaches a UK doorstep.
- A UK "stockist" is usually a reshipper. Domestic-looking storefronts frequently buy the same US or Chinese material, relabel it and post it on. You inherit their storage handling and lose the batch trail to the original certificate.
We are not going to tell you how to make a parcel less noticeable, and any page that offers to is telling you how to break customs rules. The honest summary is that this route exists, people use it, and the buyer carries every part of the risk.
What the money does not buy
The purchase is a chemical and nothing else. It does not include a pharmacist reviewing your medications, an adverse-event reporting route, a recall mechanism, or any human efficacy evidence, because there is no completed human efficacy trial. It also does not include a legal claim if the material is not what the certificate says: your recourse is the vendor's refund policy and your card issuer's chargeback process, which is why a written refund policy is worth more than a testimonial. We earn a commission on the links above, disclosed on the card and in our disclaimer.
Questions from people about to order
- What physically arrives when you buy BPC-157 peptide?
- A sealed glass vial, usually 2 mL or 3 mL, with a rubber stopper and crimp seal, containing 10 mg of freeze-dried powder that often looks like a thin film or a small disc rather than a heap. Bacteriostatic water is a separate purchase.
- Is BPC-157 the same as a compounded or prescription peptide?
- No. Compounded medicines are made by a licensed pharmacy against a prescription from bulk substances FDA permits for that use. BPC-157 is not on that list, so what you are buying is a research chemical sold under a research-use-only label.
- For BPC-157 where to buy UK, is there a legitimate British source?
- There is no MHRA-authorised product, so no UK pharmacy or clinic can supply it lawfully. UK-facing websites are research suppliers or reshippers. If you order from abroad, customs detention, import VAT and handling fees are all on you.
- Does a lower price per milligram mean lower quality peptide?
- Not by itself. A 15-residue peptide is genuinely cheap to synthesise compared with a 30-plus residue metabolic peptide, so a low per-mg figure is expected. Purity is settled by a batch-matched certificate, not by price.
- Should I buy the Wolverine Stack instead of the single vial?
- Only if you have a reason to want TB-500. The stack is BPC-157 10 mg plus TB-500 10 mg for $45.00 with the code. It is not more BPC-157, and measured against the BPC-157 alone it costs nearly twice as much per milligram as the $24.50 vial.
- Can I get BPC-157 through my GLP-1 telehealth provider?
- No. Those services prescribe approved or compounded medicines through licensed pharmacies. BPC-157 has no approval to prescribe against and no settled compounding status, so it falls outside what they can dispense.
The honest summary
Buying BPC-157 peptide means buying 10 mg of a 15-amino-acid synthetic powder from a chemical supplier, at $24.50 with the code, under a research-use label with no medical relationship attached. Check the listing against the table above, match the batch number on the vial to a certificate from a named outside lab, and understand that in the UK and EU the compound has no authorisation and the import risk is entirely yours. If the sourcing question is what brought you here rather than the molecule, the BPC-157 price breakdown has the cost side in full.
References
- Mateescu DM et al, BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers, Pharmaceutics 2026
- Vasireddi N et al, Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review, HSS Journal 2025
- MHRA, Import a human medicine
- EMA, Marketing authorisation